Sigilon Therapeutics Scores Eli Lilly Buyout And Skyrockets More Than 400% Sigilon Therapeutics Scores Eli Lilly Buyout And Skyrockets More Than 400% · Investor's Business Daily ALLISON GATLIN June 29, 2023 1 min read SGTX LLY Eli Lilly said Thursday it will buy its diabetes treatment partner, Sigilon Therapeutics, and the biotech stock skyrocketed. Continue Reading Terms and Privacy Policy Privacy Dashboard More Info